Results 91 to 100 of about 61,025 (285)
Respiratory Medicine Case Reports, 2019 Introduction: Pulmonary alveolar proteinosis is a rare disease that is characterized by accumulation of surfactant and phospholipids in the pulmonary alveoli. The current mainstay of treatment is whole lung lavage.
Haiyan Zhang
doaj +1 more source
Can somatic GATA2 mutation mimic germ line GATA2 mutation? [PDF]
, 2018 Somatic GATA2 mutation is associated with immunodeficiency and pulmonary alveolar proteinosis in a patient with myeloproliferative ...
Collin, M +7 more
core
Early IL‐1 Inhibition in Still's Disease: A Window of Opportunity for Improving Outcomes
ACR Open Rheumatology, Volume 7, Issue 10, October 2025.Objective Still's disease is a complex, multisystemic disorder requiring prompt diagnosis and treatment. This study provides a general assessment of a Still's disease cohort aiming to evaluate the efficacy of early intervention with interleukin‐1 inhibitors (IL‐1i) in achieving clinical inactive disease (CID) and reducing glucocorticoid use in patients
Sara Bindoli +5 more
wiley +1 more source
Pulmonary alveolar proteinosis in children
Breathe, 2020 Pulmonary alveolar proteinosis (PAP) is an umbrella term for a wide spectrum of conditions that have a very characteristic appearance on computed tomography.
A. Bush, R. Pabary
semanticscholar +1 more source
The Paradox of Metachronous Lipoid Pneumonia
Respirology Case Reports, Volume 13, Issue 9, September 2025.This is a case of recurrent exogenous lipoid pneumonia in a single patient caused by multiple unrelated substances. This case underscores the diagnostic value of radiologic patterns, the significance of meticulous exposure history, and the necessity of contemplating alternative aetiologies in patients with new infiltrates during cancer therapy ...
Haruki Kobayashi
wiley +1 more source
Orphanet Journal of Rare Diseases, 2007 Background Pulmonary alveolar proteinosis (PAP) is a rare disease characterised by accumulation of lipoproteinaceous material within alveoli, occurring in three clinically distinct forms: congenital, acquired and secondary.
Baritussio Aldo +7 more
doaj +1 more source
From the definition of Silicosis at the 1930 Johannesburg conference to the blurred boundaries between pneumoconioses, sarcoidosis and pulmonary alveolar proteinosis (PAP) [PDF]
, 2015 The 1930 International Labour Office Conference on silicosis in Johannesburg identified silicosis by setting a medicolegal framework to its nosology: as with other occupational illnesses, its medical content was fixed under economic pressure.
Catinon, Mickaël +4 more
core +1 more source
Pulmonary rehabilitation in pulmonary alveolar proteinosis: a case report [PDF]
, 2020 Pulmonary alveolar proteinosis is a rare lung disease in which surfactant accumulates in the alveoli causing impairment of gas exchange, pulmonary circulation, restrictive lung functions, respiratory and muscular dysfunction.
Pereira, Grace C., Rangwala, Zoeb K.
core +2 more sources
Macrophages: Subtypes, Distribution, Polarization, Immunomodulatory Functions, and Therapeutics
MedComm, Volume 6, Issue 8, August 2025.Macrophages originate from the yolk sac, fetal liver, and bone marrow, differentiating into two main subtypes: M1‐like (proinflammatory) and M2‐like (anti‐inflammatory). These subtypes exhibit high plasticity, allowing them to transform in response to environmental cues or therapeutic interventions.
Mengyuan Peng +10 more
wiley +1 more source
Pulmonary alveolar proteinosis, unusual infiltrative lung disease, the dilemma for physicians: A case report and literature review [PDF]
Journal of Analytical Research in Clinical Medicine, 2017 Introduction: Pulmonary alveolar proteinosis (PAP) is a diffuse pulmonary disease characterized by the intra-alveolar accumulation of formless, proteinaceous material.
Ali Ghavidel
doaj +1 more source